Drawing for PHASE SCIENTIFIC

USPTO serial 87901880

PHASE SCIENTIFIC

Reviewed by CopyMark Law Group

Reg. 6208297Status 700Renewal
Filing date
Status date
Registration date
Dec 1, 2020
Examiner
NEHMER, JASON ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PHASE SCIENTIFIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura M. Konkel

Laura M. Konkel Michael Best & Friedrich LLP790 N Water Street, Suite 2500Milwaukee, WI 53202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Assays for research purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Chemical preparations for scientific purposes; Chemical test kits for the expression, amplification, purification and analysis of biological samples for laboratory or research use; Chemicals for use in biotechnological product development; Chemicals for use in the biochemical and chemical industry; Protein in raw material form for scientific and medical research; Reagents for scientific and research use; Reagents for use in scientific apparatus for chemical or biological analysisACTIVE—
005Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, dental diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, S. Mutans; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of DNA, RNA, proteins, drugs, foods, pathogens and toxins; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of cancer; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of dental diseases; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of S. Mutans; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Veterinary diagnostic reagentsACTIVE—
009Bio-chips for research or scientific purposes; Medical laboratory research instruments for analysis of DNA, RNA, protein and chemicals; Medical laboratory research instruments for extraction and detection of DNA, RNA, protein, chemicals and pathogens; Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific instrumentation for measuring relative concentration of an analyte in a fluid; Scientific apparatus, namely, spectrophotometer for measuring relative DNA, RNA and proteinACTIVE—
010Medical diagnostic instruments for the analysis of body fluids; Sample preparation device for medical diagnostic usesACTIVE—
042Consulting services for others in the field of design, planning, and implementation project management of scientific research, analysis, and testing in the field of chemistry, genetics, biology and biochemistry; Research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples; Research and development and consultation related thereto in the field of chemistry, genetics, biology and biochemistry; Scientific research and developmentACTIVE—
044Medical diagnosis of human diseases, namely, genetic, infectuous, neurological, cardiovascular, cancerous, inflammatory, reproductive and developmental diseases; Medical diagnosis of ovary cancer, liver cancer, stomach cancer, pancreas cancer, esophagus cancer, colorectum cancer, lung cancer, or breast cancer; Medical diagnostic testing, monitoring and reporting servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 1, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 16, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 16, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 16, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 16, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 16, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 8, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 8, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 8, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 28, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 23, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 23, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 1, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 15, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 11, 2020OTHECASE RETURNED TO EXAMINATION—
Aug 10, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 10, 2020ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Aug 10, 2020PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Aug 5, 2020ERTITEAS RESPONSE TO PETITION INQUIRY LETTER—
Jul 22, 2020PILMPETITION INQUIRY LETTER ISSUED—
Jul 20, 2020APETASSIGNED TO PETITION STAFF—
Jun 10, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 8, 2020EX3GSOU EXTENSION 3 GRANTED—
Jun 8, 2020EXT3SOU EXTENSION 3 FILED—
Jun 8, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 26, 2020TPADTEAS PETITION TO AMEND BASIS RECEIVED—
May 7, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 7, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 7, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 7, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 7, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 22, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 20, 2019EX2GSOU EXTENSION 2 GRANTED—
Nov 20, 2019EXT2SOU EXTENSION 2 FILED—
Nov 20, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 9, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 7, 2019EX1GSOU EXTENSION 1 GRANTED—
Mar 7, 2019EXT1SOU EXTENSION 1 FILED—
Mar 7, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 11, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 26, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 6, 2018ALIEASSIGNED TO LIE—
Aug 22, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 22, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Aug 22, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 22, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 22, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 22, 2018DOCKASSIGNED TO EXAMINER—
May 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 4, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance